FDA recall D-0220-2024

InvaGen Pharmaceuticals, Inc. · Class I · drug

Product

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

Reason for recall

Defective Container: powder may leak out of the pouch

Distribution

Nationwide within the United States

Key facts

Status
Completed
Initiation date
2023-11-17
Report date
2024-01-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Central Islip, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0220-2024